Myrexis, Inc. (MYRX)

Market Cap	20.69K -98.6%
Revenue (ttm)	n/a
Net Income	-11.62M
EPS	-0.39
Shares Out	34.48M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	818
Average Volume	6,312
Open	0.0006
Previous Close	0.0005
Day's Range	0.0006 - 0.0006
52-Week Range	0.0001 - 0.0070
Beta	3.97
RSI	42.67
Earnings Date	n/a

About Myrexis

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.

• Industry: Shell Companies
• Sector: Financials
• CEO: Jonathan Couchman
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: MYRX